Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Study Phase : Discovery Platform
Sponsor : Dompe Farmaceutici
Deal Size : Undisclosed
Deal Type : Collaboration
Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration
Details : The collaboration aims to combine strengths of Eurofins Discovery’s DiscoveryOne comprehensive Integrated Drug Discovery capabilities with Dompé’s powerful supercomputing AI platform.
Brand Name : Undisclosed
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
October 10, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Technology
Highest Development Status : Discovery Platform
Sponsor : Dompe Farmaceutici
Deal Size : Undisclosed
Deal Type : Collaboration
Eurofins Discovery Collaborating with Invasight on Cancer Therapies
Details : Under the collaboration, Invasight is teaming with Eurofins Discovery's DiscoveryOne™, an integrated drug discovery platform, advancing first-in-class, small molecule, protein-protein interaction antagonists (PPIAs) against a protein that causes cancer...
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
February 14, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Study Phase : Discovery Platform
Sponsor : Amphilix
Deal Size : Undisclosed
Deal Type : Collaboration
Eurofins Discovery Collaborates with Swiss Biotech Amphilix
Details : Amphilix AG will take advantage of Eurofins Discovery's DiscoveryOne™ offering, an integrated drug discovery platform providing expert support to progress programs to preclinical development and beyond.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
November 02, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Oncology
Highest Development Status : Discovery Platform
Sponsor : Amphilix
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?